Emergent Biosolutions Inc. buy Benchmark Co.
Start price
10.04.23
/
50%
€11.36
Target price
10.04.24
€20.27
Performance (%)
-82.04%
End price
11.04.24
€2.04
Summary
This prediction ended on 11.04.24 with a price of €2.04. The BUY prediction by Benchmark_Co_ for Emergent Biosolutions Inc. performed very badly with a performance of -82.04%. Benchmark_Co_ has a follow-up prediction for Emergent Biosolutions Inc. where he still thinks Emergent Biosolutions Inc. is a Buy. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Emergent Biosolutions Inc. | 107.766% | 107.766% | -52.423% |
iShares Core DAX® | 0.476% | -0.039% | 13.342% |
iShares Nasdaq 100 | 1.290% | 0.504% | 40.099% |
iShares Nikkei 225® | 1.300% | -2.135% | 19.861% |
iShares S&P 500 | 0.829% | 0.193% | 29.756% |
Comments by Benchmark_Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
In the thread Trading Emergent Biosolutions Inc.
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.53
07.03.24
07.03.24
€4.58
07.03.25
07.03.25
62.51%
07.05.24
07.05.24
Stopped prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.04
11.04.24
11.04.24
€4.65
11.04.25
11.04.25
101.23%
07.05.24
07.05.24